| MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy? KP McGuire, J Toro-Burguete, H Dang, J Young, A Soran, M Zuley, ... Annals of surgical oncology 18, 3149-3154, 2011 | 144 | 2011 |
| Clinical relevance of microRNA expressions in breast cancer validated using the cancer genome atlas (TCGA) SY Kim, T Kawaguchi, L Yan, J Young, Q Qi, K Takabe Annals of surgical oncology 24, 2943-2949, 2017 | 82 | 2017 |
| Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients T Kawaguchi, L Yan, Q Qi, X Peng, EM Gabriel, J Young, S Liu, K Takabe Scientific reports 7 (1), 15945, 2017 | 76 | 2017 |
| Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival J Young, T Kawaguchi, L Yan, Q Qi, S Liu, K Takabe Oncotarget 8 (59), 99978, 2017 | 45 | 2017 |
| Current update of patient-derived xenograft model for translational breast cancer research T Kawaguchi, BA Foster, J Young, K Takabe Journal of mammary gland biology and neoplasia 22, 131-139, 2017 | 38 | 2017 |
| Paradoxical Association of Postoperative Plasma Sphingosine‐1‐Phosphate with Breast Cancer Aggressiveness and Chemotherapy R Ramanathan, A Raza, J Sturgill, D Lyon, J Young, NC Hait, K Takabe Mediators of Inflammation 2017 (1), 5984819, 2017 | 10 | 2017 |
| Outcome of palbociclib based therapy in hormone receptor positive metastatic breast cancer patients after treatment with everolimus. A Dhakal, C Matthews, F Zhang, EG Levine, SB Edge, KE Salerno, ... Journal of Clinical Oncology 35 (15_suppl), 1054-1054, 2017 | 5 | 2017 |
| Abstract P5-07-07: Prognostic relevance of microRNA-155 and microRNA-21 in breast cancer patients SY Kim, T Kawaguchi, L Yan, J Young, Q Qi, K Takabe Cancer Research 78 (4_Supplement), P5-07-07-P5-07-07, 2018 | 1 | 2018 |
| Meta-analysis of prognostic parameters in primary (PAS) and secondary (SAS) breast angiosarcoma. A Elkhanany, N Ammannagari, K Attwood, JS Young, JM Kane, ... Journal of Clinical Oncology 36 (15_suppl), e23525-e23525, 2018 | | 2018 |
| Abstract P5-07-08: Survival relevance of tamoxifen sensitivity-related microRNAs, miR-342 and miR-221/222, in breast cancer patients JS Young, T Kawaguchi, L Yan, Q Qi, S Liu, K Takabe Cancer Research 78 (4_Supplement), P5-07-08-P5-07-08, 2018 | | 2018 |
| Abstract P2-05-14: Young breast cancer patients (< 40 yo) have unfavorable subtypes, higher stage and worse survival JS Young, T Kawaguchi, L Yan, Q Qi, S Liu, K Takabe Cancer Research 78 (4_Supplement), P2-05-14-P2-05-14, 2018 | | 2018 |
